BioSpace News Archive

Seagen Inc. (Nasdaq: SGEN) today announced plans to build a new facility in Everett, Washington, to expand the company’s biomanufacturing capacity and enable the company greater control and flexibility over the production of its medicines to treat cancer.

Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced the closing of its previously announced private placement of 1,180,812 shares of common stock (or common stock equivalents in lieu thereof), that was priced at-the-market under Nasdaq rules.

Breckenridge Pharmaceutical, Inc. announced today that it has launched Pencillamine Capsules, USP (generic for Cuprimine®).

Moving beyond the proven tech and best-selling success of the i700 intraoral scanner, MEDIT announces the release of the i700 wireless – newly designed as a portable wand with the same speed, accuracy, and lightness.

Reducing postharvest losses could substantially increase food availability, reducing pressure on the mounting food supply shortage and global inflationary pressures with respect to food prices. In addition, food production could be more environmentally sustainable with less waste.

Rise in the prevalence of different types of cancers such as lung cancer, blood cancer, and brain tumor drives the global digital PCR market.

Surge in funding of R&D activities for cancer gene therapy along with the rising in the prevalence of cancer and supportive government regulations drive the growth of the global cancer gene therapy market.

Rise in digital dependence and industry 4.0 trends present new opportunities in the coming years. Rise in number of cyber-attacks and increase in demand for cloud services drive the growth of the global healthcare cyber security market.

Increasing investment from pharmaceutical companies to develop vaccines to prevent biothreats is expected to drive market revenue growth.

Increasing prevalence of life-threatening diseases and development of smart wearable devices is driving injectable drug delivery market revenue growth.